Artificial intelligence and machine learning are reshaping how investors build and maintain portfolios. These tools bring ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

The announcement came as Hegseth faces intense scrutiny over a controversial Sept. 2 "double-tap" strike. by Olivia-Anne Cleary by Chad de Guzman by Neale Mahoney and Adam Shaw Advertisement The Skims ...